BioNTech收购了中国Biotheus公司,以促进癌症研究工作。 BioNTech acquires Chinese firm Biotheus to boost cancer research efforts.

BioNTEch是一家领先的生物技术公司,正在收购总部设在中国的Biotheus公司,以加强其癌症治疗研究与开发工作。 BioNTech, a leading biotech company, is acquiring China-based Biotheus to enhance its cancer treatment research and development efforts. 此举旨在通过整合Biotheus的先进技术和资源,加强BioNtech的肿瘤学战略。 The move aims to strengthen BioNTech's oncology strategy by integrating Biotheus's advanced technology and resources. 购置的财务细节没有披露。 Financial details of the acquisition were not disclosed.